Journal Article

The effect of endothelin antagonists on renal ischaemia‐reperfusion injury and the development of acute renal failure in the rat

Chunlong Huang, Chunhua Huang, Dominique Hestin, Paul C. Dent, Paul Barclay, Michael Collis and Edward J. Johns

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue 9, pages 1578-1585
Published in print September 2002 | ISSN: 0931-0509
Published online September 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.9.1578
The effect of endothelin antagonists on renal ischaemia‐reperfusion injury and the development of acute renal failure in the rat

Show Summary Details

Preview

Background. It is recognized that endothelins are released in response to hypoperfusion and anoxia of the kidney and may be responsible for the consequent deterioration in renal function. This study examined the ability of a non‐selective (SB209670) and ETA‐selective (UK‐350,926) endothelin antagonist to attenuate ischaemia‐induced renal failure in unilaterally nephrectomized rats.

Methods. The animals were anaesthetized, drug infusion commenced, and the renal artery occluded for 30 min. The endothelin antagonists were given for 30 min before, during, and 60 min after the ischaemic period, at 10, 30 and 100 μg/kg/min or for 60 min after the start of reperfusion.

Results. On day 1, following 30 min renal artery occlusion, there was a 95% reduction in glomerular filtration rate, an 8–10‐fold increase in plasma creatinine, and 10–15‐fold increases in fractional excretions of sodium and potassium, which were partially resolved on day 3 and normalized on day 8. The lowest dose of SB209670 was without effect on the renal functional responses but they were blunted (all P<0.05) by the highest dose. At 30 and 100 μg/kg/min UK‐350,926, the decreases in renal function subsequent to the ischaemic challenge were attenuated. Administration of UK‐350,926 at 100 μg/kg/min for 1 h starting 60 min after the start of reperfusion, had no effect on the magnitude of the renal disturbances over the first 3 days.

Conclusions. The data show that both the ETA/ETB and selective ETA‐receptor antagonist ameliorated the ischaemia‐reperfusion injury when given in the peri‐ischaemic period but not when the ETA‐receptor antagonist was given for 60 min at 100 μg/kg/min after the ischaemic period.

Keywords: acute renal failure; endothelin antagonists; renal haemodynamics; urinary sodium excretion

Journal Article.  5118 words.  Illustrated.

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.